TrialNature communications2024

Neoadjuvant chemo-immunotherapy with camrelizumab plus nab-paclitaxel and cisplatin in resectable locally advanced squamous cell carcinoma of the head and neck: a pilot phase II trial.

Di Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.